Printer Friendly
The Free Library
14,678,647 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Stalking a vaccine for skin cancer.


Stalking a vaccine for skin cancer

Taking some of the hair of the dog that bit you mab prove sound advice when it comes to skin cancer.

David Berd, an oncologist at Thomas Jefferson University It began as Jefferson Medical College in 1824. On July 1, 1969 the institution officially became Thomas Jefferson University.

The university is made up of three colleges:
  • Jefferson Medical College
  • Jefferson College of Graduate Studies
 in Philadelphia, injected 24 patients who had metastatic Metastatic
The term used to describe a secondary cancer, or one that has spread from one area of the body to another.

Mentioned in: Coagulation Disorders


metastatic

pertaining to or of the nature of a metastasis.
 melanoma with pieces of their own tumors coated with the immune-system sensitizing sen·si·tize  
v. sen·si·tized, sen·si·tiz·ing, sen·si·tiz·es

v.tr.
1. To make sensitive: "The polarity principle . . .
 agent dinitrophenyl. This month, at the First International Symposium on Combination Therapies in Washington, D.C., he reported that 14 of the volunteers developed an increased immune response immune response
n.
An integrated bodily response to an antigen, especially one mediated by lymphocytes and involving recognition of antigens by specific antibodies or previously sensitized lymphocytes.
 to their cancers.

In an earlier study using uncoated tumor cells, Berd found that five of 40 patients showed significant tumor regression. Despite melanoma's extremely high mortality, one patient is still alive eight years after diagnosis, he says. These studies "provide some basis for optimism" about the prospect of developing a vaccine to boost immune responses to melanoma and possibly other cancers, he conludes.
COPYRIGHT 1991 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:metastatic melanoma
Publication:Science News
Date:Mar 30, 1991
Words:147
Previous Article:Shocking treatment proposed for AIDS. (zapping the AIDS virus with low-voltage electric current)
Next Article:Totally organic electronics. (semiconductors fashioned from organic molecules)
Topics:



Related Articles
Taking a shot at melanoma. (research on antimelanoma vaccine)
'Vaccine' spurs immune attack on melanoma.
Waving a red flag against melanoma.
Is that mole friend or foe? (diagnosing malignant melanoma)
MELANOMA 2001.(Brief Article)
Anal Melanoma: An Aggressive Malignancy Masquerading as Hemorrhoids.
Unorthodox strategy: new cancer vaccine may thwart melanoma.(This Week)
AVAX Technologies Announces Special Protocol Assessment Agreement with FDA for a Phase III Clinical Trial of M-Vax in Metastatic Melanoma.
Synta Pharmaceuticals Announces FDA Fast Track Designation for STA-4783 in Metastatic Melanoma.
AVAX Technologies Launches Global Phase III Registration Clinical Trial of M-Vax in Metastatic Melanoma.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles